What to expect in the MBX Biosciences, Inc. interview process

Based on publicly available sources, MBX Biosciences, Inc. is a clinical-stage biopharmaceutical and biotechnology research company founded in 2019. Headquartered in Carmel, Indiana, with an additional office in Burlington, Massachusetts, the company operates with a relatively small and rapidly expanding team. Employee counts place the organization between approximately 51 and 100 people, reflecting a notable headcount growth of roughly 50% year-over-year (adding about 29 people to reach roughly 66 to 88 employees).

The company is focused on precision peptide therapies for endocrine and metabolic disorders, utilizing its proprietary Precision Endocrine Peptides (PEPs) platform, with pipeline candidates such as MBX 2109 for hypoparathyroidism. Public records show active recruitment across research, clinical, regulatory, and information technology functions, supported by internal leadership including a Chief Human Resources Officer (Michelle Graham) and an Associate Director of Talent Acquisition (Jessica Snow). Workplace communications highlight structured employee recognition events, such as Employee Appreciation Day messages from HR leadership, alongside ongoing leadership expansions like the appointment of a Chief Commercial Officer and a Vice President of Biometrics.